Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant

Beta (B.1.351)–variant coronavirus disease 2019 (COVID-19) disease was investigated in Qatar. Compared with the Alpha (B.1.1.7) variant, odds (95% confidence interval) of progressing to severe disease, critical disease, and COVID-19–related death were 1.24-fold (1.11–1.39), 1.49-fold (1.13–1.97), an...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Raddad, Laith J, Chemaitelly, Hiam, Ayoub, Houssein H, Yassine, Hadi M, Benslimane, Fatiha M, Al Khatib, Hebah A, Tang, Patrick, Hasan, Mohammad R, Coyle, Peter, AlMukdad, Sawsan, Al Kanaani, Zaina, Al Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul Rahim, Hanan F, Nasrallah, Gheyath K, Al Kuwari, Mohamed Ghaith, Butt, Adeel A, Al Romaihi, Hamad Eid, Al-Thani, Mohamed H, Al Khal, Abdullatif, Bertollini, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402694/
https://www.ncbi.nlm.nih.gov/pubmed/34657152
http://dx.doi.org/10.1093/cid/ciab909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402694/
https://www.ncbi.nlm.nih.gov/pubmed/34657152
http://dx.doi.org/10.1093/cid/ciab909

Ejemplares similares